Beta Bionics (BBNX) Assets Average (2025 - 2026)
Beta Bionics recorded quarterly Assets Average of $316.6 million in Q1 2026, down 3.89% quarter-over-quarter from $329.4 million in Q4 2025, and up 29.83% year-over-year from $243.8 million in Q1 2025.
Beta Bionics' Assets Average history runs 2 years deep, the most recent figure standing at $316.6 million for Q1 2026.
- In Q1 2026, Assets Average rose 29.83% year-over-year to $316.6 million; the TTM figure through Mar 2026 stood at $316.6 million (up 29.83% YoY), while the FY2025 annual figure was $239.2 million, up 84.22% from the prior year.
- Assets Average came in at $316.6 million for Q1 2026 at Beta Bionics, down from $329.4 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $334.0 million in Q2 2025 to a low of $243.8 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.42 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.64 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.49 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.02 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.66 Bn |
| 10 | Beta Bionics | 572.34 Mn | 542.03 Mn | 16.44 Mn | 316.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 316.58 Mn |
| Dec 31, 2025 | 329.39 Mn |
| Sep 30, 2025 | 330.01 Mn |
| Jun 30, 2025 | 334.00 Mn |
| Mar 31, 2025 | 243.83 Mn |